[HTML][HTML] Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto… - The Journal of …, 2017 - Am Soc Clin Investig
Parkinson's disease (PD) patients experience loss of normal motor function (hypokinesia),
but can develop uncontrollable movements known as dyskinesia upon treatment with L …

Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto… - Journal of Clinical …, 2017 - lup.lub.lu.se
Parkinson's disease (PD) patients experience loss of normal motor function (hypokinesia),
but can develop uncontrollable movements known as dyskinesia upon treatment with L …

Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto… - Journal of Clinical …, 2017 - portal.research.lu.se
Parkinson's disease (PD) patients experience loss of normal motor function (hypokinesia),
but can develop uncontrollable movements known as dyskinesia upon treatment with L …

Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli… - The Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) patients experience loss of normal motor function (hypokinesia),
but can develop uncontrollable movements known as dyskinesia upon treatment with L …

[PDF][PDF] Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto, J Jakobsson… - molecular-neurogenetics.lu.se
Our capacity to perform well-coordinated movements depends on the activity of 2 pathways
linking the striatum with deep basal ganglia nuclei. The direct pathway originates from …

Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto… - Journal of Clinical …, 2017 - go.gale.com
Parkinson's disease (PD) patients experience loss of normal motor function (hypokinesia),
but can develop uncontrollable movements known as dyskinesia upon treatment with L …

[PDF][PDF] Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto, J Jakobsson… - researchgate.net
Our capacity to perform well-coordinated movements depends on the activity of 2 pathways
linking the striatum with deep basal ganglia nuclei. The direct pathway originates from …

Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy.

C Alcacer, L Andreoli, I Sebastianutto… - The Journal of …, 2017 - europepmc.org
Parkinson's disease (PD) patients experience loss of normal motor function (hypokinesia),
but can develop uncontrollable movements known as dyskinesia upon treatment with L …

[HTML][HTML] Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto… - The Journal of …, 2017 - ncbi.nlm.nih.gov
Parkinson's disease (PD) patients experience loss of normal motor function (hypokinesia),
but can develop uncontrollable movements known as dyskinesia upon treatment with L …

[引用][C] Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy

C Alcacer, L Andreoli, I Sebastianutto… - Journal of Clinical …, 2017 - cir.nii.ac.jp
Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson’s
disease therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …